Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSA™ (vibegron under the international non-proprietary name) for the symptomatic treatment of adult patients with overactive bladder syndrome (OAB). Pierre Fabre Laboratories acquired an exclusive license from Urovant Sciences to register and commercialize vibegron in the European Economic Area in 202
"The Crewmates" from Irvine High School in Irvine, Calif., are the champions of AFA's 2023-2024 StellarXplorers National Space Design Competition.
NEW YORK, April 26, 2024--Segal Marco Advisors, one of the largest U.S.-based investment consultancies, has received a 2024 Greenwich Quality Leader award for Overall U.S. Investment Consulting in the Large Consultants category by Coalition Greenwich, a leading global provider of data, analytics and insights to the financial services industry. This is the sixth time that Segal Marco has been given this honor, a direct reflection of the company’s dedication to outstanding client satisfaction.
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|
Símbolo | Último precio | Cambio | Cambio de % |
---|---|---|---|